163. Consulting the Crystal Ball of Biology: Karl & Erum's 2026 Predictions

Episode notes

Karl and Erum kick off 2026 by reviewing their 2025 forecasts - celebrating the wins (DeSci's rise, waste as a resource, AI-biology convergence) and acknowledging the misses (no biotech M&A boom, no quantum biology breakthrough yet). Then they unveil their boldest predictions for the year ahead: the first functional AI-composed genome entering production, a major non-sterile biomanufacturing facility breaking ground, biological arbitrage creating competitive advantages against tariffs, consumer-held health records surpassing traditional medical data in clinical significance, space-manufactured drug crystals entering human trials, definitive proof of alien life, and AI-enabled communication with whales and other animals. They also welcome Lizette Couto, who joins the podcast to provide science definitions and explanations throughout episodes going forward. From dirty biology manifestos to peptide proliferation to interspecies communication, this episode maps the frontiers where synthetic biology, AI, space technology, and consumer adoption collide. Grow Everything brings the bioeconomy to life.

• 186. N.Y. Tech Week Live Demo: Engineering the Future of Manufacturing with Roebling's Brentan Alexander52 / 100
• 185. Brick Happens: Chris Maurer of Redhouse Studio Redesigns Remote Living for Earth and Mars55 / 100
• 184. The Multiverse of Microbes: Henry Lee on Building Cultivarium and Training with Titans45 / 100
• 183. The American Biotech Blueprint: Senator Todd Young on Biodiversity as National Security
• 182. SynBioBeta 2026 Recap, It's Biologist Approved